Vn96 is a highly effective and flexible tool for the isolation and purification of pathological exosomes that aims at improving and accelerating molecular diagnostics and therapeutic technologies.
Tagged with: Vn96
RNA-Seq of Exosomes
February 7, 2023
Infographic – Exosomes: The Essentials
December 9, 2022
Targeted drug delivery using exosomes
November 29, 2022
Antenatal administration of amniotic fluid stem cell extracellular vesicles rescues development
November 9, 2022
New data shows stem cell derived exosome platform provides a significant increase in delivery of siRNA compared to a conventional exosome approaches
October 10, 2022
The patent protected Vn96 peptide reagent is designed to bind specifically to canonical Heat Shock Proteins (HSPs) that line the exterior of EVs originating from stressed cells such as cancer cells.
You can view our recent open-access publication for Vn96 at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0110443
The peptide is available for your research through New England Peptide:
Contact Excipio Technologies for Licensing and collaboration opportunities at email@example.com
When it comes to exosome isolation technology, there are many options now, including Ultrafiltration method, Polypolymer precipitation method, Magnetic bead immunoassay, Aqueous two phase system (ATPS) method, etc. And exosome isolation is very popular now.